Gene therapy to target ER stress in brain diseases

Brain Research

Volumn 1648, Issue , 2016, Pages 561-570

  Valenzuela, Vicente ^a,b,c   Martínez, Gabriela ^a,b,c   Duran Aniotz, Claudia ^a,b,c   Hetz, Claudio ^a,b,c,d,e  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c Universidad de Chile and Geroscience Center for Brain Health and Metabolism   (Chile)

^d BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Endoplasmic reticulum stress; Gene therapy; Parkinson's disease; Unfolded protein response

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DISEASE; DEGENERATIVE DISEASE; ENDOPLASMIC RETICULUM STRESS; GENE THERAPY; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; REVIEW; ANIMAL; DEPENDOPARVOVIRUS; GENETICS; PHYSIOLOGY; PROCEDURES; UNFOLDED PROTEIN RESPONSE;

ANIMALS; BRAIN DISEASES; DEPENDOVIRUS; ENDOPLASMIC RETICULUM STRESS; GENETIC THERAPY; HUMANS; UNFOLDED PROTEIN RESPONSE;

EID: 84966708289     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2016.04.064     Document Type: Review

References (144)

1. Acosta-Alvear, D., Zhou, Y., Blais, A., Tsikitis, M., Lents, N.H., Arias, C., Lennon, C.J., Kluger, Y., Dynlacht, B.D., XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol. Cell 27 (2007), 53–66.
2. Arimura, N., Kaibuchi, K., Neuronal polarity: from extracellular signals to intracellular mechanisms. Nat. Rev. Neurosci. 8 (2007), 194–205.
3. Balch, W.E., Morimoto, R.I., Dillin, A., Kelly, J.W., Adapting proteostasis for disease intervention. Science 319 (2008), 916–919.
4. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., Jones, E., Alzheimer's disease. Lancet 377 (2011), 1019–1031.
5. Baumer, D., Talbot, K., Turner, M.R., Advances in motor neurone disease. J. R. Soc. Med. 107 (2014), 14–21.
6. Benkhelifa-Ziyyat, S., Besse, A., Roda, M., Duque, S., Astord, S., Carcenac, R., Marais, T., Barkats, M., Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice. Mol. Ther.: J. Am. Soc. Gene Ther. 21 (2013), 282–290.
7. Bernard-Marissal, N., Sunyach, C., Marissal, T., Raoul, C., Pettmann, B., Calreticulin levels determine onset of early muscle denervation by fast motoneurons of ALS model mice. Neurobiol. Dis., 2014.
8. Bilican, B., Serio, A., Barmada, S.J., Nishimura, A.L., Sullivan, G.J., Carrasco, M., Phatnani, H.P., Puddifoot, C.A., Story, D., Fletcher, J., Park, I.H., Friedman, B.A., Daley, G.Q., Wyllie, D.J., Hardingham, G.E., Wilmut, I., Finkbeiner, S., Maniatis, T., Shaw, C.E., Chandran, S., Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells". Sci. Transl. Med., 5, 2013 (188le2).
9. Bourdenx, M., Dutheil, N., Bezard, E., Dehay, B., Systemic gene delivery to the central nervous system using Adeno-associated virus. Front. Mol. Neurosci., 7, 2014, 50.
10. Cajigas, I.J., Will, T., Schuman, E.M., Protein homeostasis and synaptic plasticity. EMBO J. 29 (2010), 2746–2752.
11. Castillo, K., Nassif, M., Valenzuela, V., Rojas, F., Matus, S., Mercado, G., Court, F.A., van Zundert, B., Hetz, C., Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy 9 (2013), 1308–1320.
12. Castillo, V., Mercado, G., Hetz, C., Gene therapy in Parkinson's disease: targeting the endplasmic reticulum proteostasis network. Neural Regen. Res. 10 (2015), 1053–1054.
13. Castillo, V., Onate, M., Woehlbier, U., Rozas, P., Andreu, C., Medinas, D., Valdes, P., Osorio, F., Mercado, G., Vidal, R.L., Kerr, B., Court, F.A., Hetz, C., Functional role of the disulfide isomerase ERp57 in axonal regeneration. PLoS One, 10, 2015, e0136620.
14. Cleary, J.P., Walsh, D.M., Hofmeister, J.J., Shankar, G.M., Kuskowski, M.A., Selkoe, D.J., Ashe, K.H., Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8 (2005), 79–84.
15. Colla, E., Coune, P., Liu, Y., Pletnikova, O., Troncoso, J.C., Iwatsubo, T., Schneider, B.L., Lee, M.K., Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo. J. Neurosci.: Off. J. Soc. Neurosci. 32 (2012), 3306–3320.
16. Colla, E., Jensen, P.H., Pletnikova, O., Troncoso, J.C., Glabe, C., Lee, M.K., Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo. J. Neurosci.: Off. J. Soc. Neurosci. 32 (2012), 3301–3305.
17. Conn, K.J., Gao, W., McKee, A., Lan, M.S., Ullman, M.D., Eisenhauer, P.B., Fine, R.E., Wells, J.M., Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res. 1022 (2004), 164–172.
18. Cooper, A.A., Gitler, A.D., Cashikar, A., Haynes, C.M., Hill, K.J., Bhullar, B., Liu, K., Xu, K., Strathearn, K.E., Liu, F., Cao, S., Caldwell, K.A., Caldwell, G.A., Marsischky, G., Kolodner, R.D., Labaer, J., Rochet, J.C., Bonini, N.M., Lindquist, S., Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313 (2006), 324–328.
19. Cornejo, V.H., Hetz, C., The unfolded protein response in Alzheimer's disease. Semin. Immunopathol. 35 (2013), 277–292.
20. Costa-Mattioli, M., Gobert, D., Harding, H., Herdy, B., Azzi, M., Bruno, M., Bidinosti, M., Ben Mamou, C., Marcinkiewicz, E., Yoshida, M., Imataka, H., Cuello, A.C., Seidah, N., Sossin, W., Lacaille, J.C., Ron, D., Nader, K., Sonenberg, N., Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 436 (2005), 1166–1173.
21. Costa-Mattioli, M., Sossin, W.S., Klann, E., Sonenberg, N., Translational control of long-lasting synaptic plasticity and memory. Neuron 61 (2009), 10–26.
22. Coune, P.G., Bensadoun, J.C., Aebischer, P., Schneider, B.L., Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease. J. Parkinson's Dis. 1 (2011), 373–387.
23. Coune, P.G., Schneider, B.L., Aebischer, P., Parkinson's disease: gene therapies. Cold Spring Harb. Perspect. Med., 2, 2012, a009431.
24. Credle, J.J., Forcelli, P.A., Delannoy, M., Oaks, A.W., Permaul, E., Berry, D.L., Duka, V., Wills, J., Sidhu, A., alpha-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease. Neurobiol. Dis. 76 (2015), 112–125.
25. Cubillos-Ruiz, J.R., Silberman, P.C., Rutkowski, M.R., Chopra, S., Perales-Puchalt, A., Song, M., Zhang, S., Bettigole, S.E., Gupta, D., Holcomb, K., Ellenson, L.H., Caputo, T., Lee, A.H., Conejo-Garcia, J.R., Glimcher, L.H., ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell 161 (2015), 1527–1538.
26. Chen, X., Iliopoulos, D., Zhang, Q., Tang, Q., Greenblatt, M.B., Hatziapostolou, M., Lim, E., Tam, W.L., Ni, M., Chen, Y., Mai, J., Shen, H., Hu, D.Z., Adoro, S., Hu, B., Song, M., Tan, C., Landis, M.D., Ferrari, M., Shin, S.J., Brown, M., Chang, J.C., Liu, X.S., Glimcher, L.H., XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature 508 (2014), 103–107.
27. Chung, C.Y., Khurana, V., Auluck, P.K., Tardiff, D.F., Mazzulli, J.R., Soldner, F., Baru, V., Lou, Y., Freyzon, Y., Cho, S., Mungenast, A.E., Muffat, J., Mitalipova, M., Pluth, M.D., Jui, N.T., Schule, B., Lippard, S.J., Tsai, L.H., Krainc, D., Buchwald, S.L., Jaenisch, R., Lindquist, S., Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 342 (2013), 983–987.
28. Das, I., Krzyzosiak, A., Schneider, K., Wrabetz, L., D'Antonio, M., Barry, N., Sigurdardottir, A., Bertolotti, A., Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science 348 (2015), 239–242.
29. Devi, L., Ohno, M., Deletion of the eIF2alpha Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease. PLoS One, 8, 2013, e77335.
30. Dion, A., 2015. PharmaSphere: Emerging Biotechnologies – Gene Therapy Market Analysis, vol. 1, ed. GlobalData.
31. Donnelly, C.J., Zhang, P.W., Pham, J.T., Haeusler, A.R., Mistry, N.A., Vidensky, S., Daley, E.L., Poth, E.M., Hoover, B., Fines, D.M., Maragakis, N., Tienari, P.J., Petrucelli, L., Traynor, B.J., Wang, J., Rigo, F., Bennett, C.F., Blackshaw, S., Sattler, R., Rothstein, J.D., RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80 (2013), 415–428.
32. Drogat, B., Auguste, P., Nguyen, D.T., Bouchecareilh, M., Pineau, R., Nalbantoglu, J., Kaufman, R.J., Chevet, E., Bikfalvi, A., Moenner, M., IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res. 67 (2007), 6700–6707.
33. Duque, S., Joussemet, B., Riviere, C., Marais, T., Dubreil, L., Douar, A.M., Fyfe, J., Moullier, P., Colle, M.A., Barkats, M., Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol. Ther.: J. Am. Soc. Gene Ther. 17 (2009), 1187–1196.
34. Duran-Aniotz, C., Martinez, G., Hetz, C., Memory loss in Alzheimer's disease: are the alterations in the UPR network involved in the cognitive impairment?. Front. Aging Neurosci., 6, 2014, 8.
35. Egawa, N., Yamamoto, K., Inoue, H., Hikawa, R., Nishi, K., Mori, K., Takahashi, R., The endoplasmic reticulum stress sensor, ATF6alpha, protects against neurotoxin-induced dopaminergic neuronal death. J. Biol. Chem. 286 (2011), 7947–7957.
36. Filezac de L'Etang, A., Maharjan, N., Cordeiro Brana, M., Ruegsegger, C., Rehmann, R., Goswami, A., Roos, A., Troost, D., Schneider, B.L., Weis, J., Saxena, S., Marinesco-Sjogren syndrome protein SIL1 regulates motor neuron subtype-selective ER stress in ALS. Nat. Neurosci. 18 (2015), 227–238.
37. Flotte, T.R., Afione, S.A., Zeitlin, P.L., Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11 (1994), 517–521.
38. Foust, K.D., Poirier, A., Pacak, C.A., Mandel, R.J., Flotte, T.R., Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons. Hum. Gene Ther. 19 (2008), 61–70.
39. Foust, K.D., Nurre, E., Montgomery, C.L., Hernandez, A., Chan, C.M., Kaspar, B.K., Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27 (2009), 59–65.
40. Freeman, O.J., Mallucci, G.R., The UPR and synaptic dysfunction in neurodegeneration. Brain Res., 2016.
41. Gombash, S.E., Cowley, C.J., Fitzgerald, J.A., Hall, J.C., Mueller, C., Christofi, F.L., Foust, K.D., Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice. Front. Mol. Neurosci., 7, 2014, 81.
42. Gomez-Isla, T., Spires, T., De Calignon, A., Hyman, B.T., Neuropathology of Alzheimer's disease. Handb. Clin. Neurol. 89 (2008), 233–243.
43. Gonzalez-Perez, P., Woehlbier, U., Chian, R.J., Sapp, P., Rouleau, G.A., Leblond, C.S., Daoud, H., Dion, P.A., Landers, J.E., Hetz, C., Brown, R.H., Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients. Gene 566 (2015), 158–165.
44. Gorbatyuk, M.S., Knox, T., LaVail, M.M., Gorbatyuk, O.S., Noorwez, S.M., Hauswirth, W.W., Lin, J.H., Muzyczka, N., Lewin, A.S., Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78. Proc. Natl. Acad. Sci. USA 107 (2010), 5961–5966.
45. Gorbatyuk, M.S., Shabashvili, A., Chen, W., Meyers, C., Sullivan, L.F., Salganik, M., Lin, J.H., Lewin, A.S., Muzyczka, N., Gorbatyuk, O.S., Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease. Mol. Ther.: J. Am. Soc. Gene Ther. 20 (2012), 1327–1337.
46. Gray, S.J., Foti, S.B., Schwartz, J.W., Bachaboina, L., Taylor-Blake, B., Coleman, J., Ehlers, M.D., Zylka, M.J., McCown, T.J., Samulski, R.J., Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum. Gene Ther. 22 (2011), 1143–1153.
47. Griciuc, A., Aron, L., Ueffing, M., ER stress in retinal degeneration: a target for rational therapy?. Trends Mol. Med. 17 (2011), 442–451.
48. Halliday, M., Mallucci, G.R., Review: modulating the unfolded protein response to prevent neurodegeneration and enhance memory. Neuropathol. Appl. Neurobiol. 41 (2015), 414–427.
49. Han, J., Back, S.H., Hur, J., Lin, Y.H., Gildersleeve, R., Shan, J., Yuan, C.L., Krokowski, D., Wang, S., Hatzoglou, M., Kilberg, M.S., Sartor, M.A., Kaufman, R.J., ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol. 15 (2013), 481–490.
50. Harding, H.P., Zhang, Y., Bertolotti, A., Zeng, H., Ron, D., Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 5 (2000), 897–904.
51. Harding, H.P., Zhang, Y., Zeng, H., Novoa, I., Lu, P.D., Calfon, M., Sadri, N., Yun, C., Popko, B., Paules, R., Stojdl, D.F., Bell, J.C., Hettmann, T., Leiden, J.M., Ron, D., An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11 (2003), 619–633.
52. Hashida, K., Kitao, Y., Sudo, H., Awa, Y., Maeda, S., Mori, K., Takahashi, R., Iinuma, M., Hori, O., ATF6alpha promotes astroglial activation and neuronal survival in a chronic mouse model of Parkinson's disease. PLoS One, 7, 2012, e47950.
53. Hetz, C., Thielen, P., Fisher, J., Pasinelli, P., Brown, R.H., Korsmeyer, S., Glimcher, L., The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis. Cell Death Differ. 14 (2007), 1386–1389.
54. Hetz, C., Glimcher, L.H., Fine-tuning of the unfolded protein response: assembling the IRE1alpha interactome. Mol. Cell 35 (2009), 551–561.
55. Hetz, C., Thielen, P., Matus, S., Nassif, M., Court, F., Kiffin, R., Martinez, G., Cuervo, A.M., Brown, R.H., Glimcher, L.H., XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev. 23 (2009), 2294–2306.
56. Hetz, C., The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13 (2012), 89–102.
57. Hetz, C., Chevet, E., Harding, H.P., Targeting the unfolded protein response in disease. Nat. Rev. Drug Discov. 12 (2013), 703–719.
58. Hetz, C., Mollereau, B., Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 15 (2014), 233–249.
59. Hetz, C., Chevet, E., Oakes, S.A., Proteostasis control by the unfolded protein response. Nat. Cell Biol. 17 (2015), 829–838.
60. Hoozemans, J.J., van Haastert, E.S., Eikelenboom, P., de Vos, R.A., Rozemuller, J.M., Scheper, W., Activation of the unfolded protein response in Parkinson's disease. Biochem. Biophys. Res. Commun. 354 (2007), 707–711.
61. Hoozemans, J.J., van Haastert, E.S., Nijholt, D.A., Rozemuller, A.J., Eikelenboom, P., Scheper, W., The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am. J. Pathol. 174 (2009), 1241–1251.
62. Hoozemans, J.J., Scheper, W., Endoplasmic reticulum: the unfolded protein response is tangled in neurodegeneration. Int. J. Biochem. Cell Biol. 44 (2012), 1295–1298.
63. Hu, Y., Park, K.K., Yang, L., Wei, X., Yang, Q., Cho, K.S., Thielen, P., Lee, A.H., Cartoni, R., Glimcher, L.H., Chen, D.F., He, Z., Differential effects of unfolded protein response pathways on axon injury-induced death of retinal ganglion cells. Neuron 73 (2012), 445–452.
64. Huang, H.C., Tang, D., Lu, S.Y., Jiang, Z.F., Endoplasmic reticulum stress as a novel neuronal mediator in Alzheimer's disease. Neurol. Res. 37 (2015), 366–374.
65. Jiang, H.Q., Ren, M., Jiang, H.Z., Wang, J., Zhang, J., Yin, X., Wang, S.Y., Qi, Y., Wang, X.D., Feng, H.L., Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neuroscience 277 (2014), 132–138.
66. Jiang, Z., Belforte, J.E., Lu, Y., Yabe, Y., Pickel, J., Smith, C.B., Je, H.S., Lu, B., Nakazawa, K., eIF2alpha phosphorylation-dependent translation in CA1 pyramidal cells impairs hippocampal memory consolidation without affecting general translation. J. Neurosci. 30 (2010), 2582–2594.
67. Kakiuchi, C., Iwamoto, K., Ishiwata, M., Bundo, M., Kasahara, T., Kusumi, I., Tsujita, T., Okazaki, Y., Nanko, S., Kunugi, H., Sasaki, T., Kato, T., Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat. Genet. 35 (2003), 171–175.
68. Kakiuchi, C., Ishiwata, M., Umekage, T., Tochigi, M., Kohda, K., Sasaki, T., Kato, T., Association of the XBP1-116C/G polymorphism with schizophrenia in the Japanese population. Psychiatry Clin. Neurosci. 58 (2004), 438–440.
69. Kaushik, S., Cuervo, A.M., Proteostasis and aging. Nat. Med. 21 (2015), 1406–1415.
70. Kiskinis, E., Sandoe, J., Williams, L.A., Boulting, G.L., Moccia, R., Wainger, B.J., Han, S., Peng, T., Thams, S., Mikkilineni, S., Mellin, C., Merkle, F.T., Davis-Dusenbery, B.N., Ziller, M., Oakley, D., Ichida, J., Di Costanzo, S., Atwater, N., Maeder, M.L., Goodwin, M.J., Nemesh, J., Handsaker, R.E., Paull, D., Noggle, S., McCarroll, S.A., Joung, J.K., Woolf, C.J., Brown, R.H., Eggan, K., Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14 (2014), 781–795.
71. Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., Takahashi, K., Asaka, I., Aoi, T., Watanabe, A., Watanabe, K., Kadoya, C., Nakano, R., Watanabe, D., Maruyama, K., Hori, O., Hibino, S., Choshi, T., Nakahata, T., Hioki, H., Kaneko, T., Naitoh, M., Yoshikawa, K., Yamawaki, S., Suzuki, S., Hata, R., Ueno, S.I., Seki, T., Kobayashi, K., Toda, T., Murakami, K., Irie, K., Klein, W.L., Mori, H., Asada, T., Takahashi, R., Iwata, N., Yamanaka, S., Inoue, H., Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular abeta and differential drug responsiveness. Cell Stem Cell., 2013.
72. Krstic, D., Knuesel, I., Deciphering the mechanism underlying late-onset Alzheimer disease. Nat. Rev. Neurol. 9 (2013), 25–34.
73. Leblond, C.S., Kaneb, H.M., Dion, P.A., Rouleau, G.A., Dissection of genetic factors associated with amyotrophic lateral sclerosis. Exp. Neurol., 2014, 91–101.
74. Lee, A.H., Iwakoshi, N.N., Glimcher, L.H., XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell Biol. 23 (2003), 7448–7459.
75. Lee, V.M., Goedert, M., Trojanowski, J.Q., Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24 (2001), 1121–1159.
76. Lin, J.H., Li, H., Yasumura, D., Cohen, H.R., Zhang, C., Panning, B., Shokat, K.M., Lavail, M.M., Walter, P., IRE1 signaling affects cell fate during the unfolded protein response. Science 318 (2007), 944–949.
77. Liu, S.Y., Wang, W., Cai, Z.Y., Yao, L.F., Chen, Z.W., Wang, C.Y., Zhao, B., Li, K.S., Polymorphism-116C/G of human X-box-binding protein 1 promoter is associated with risk of Alzheimer's disease. CNS Neurosci. Ther. 19 (2013), 229–234.
78. Lourenco, M.V., Clarke, J.R., Frozza, R.L., Bomfim, T.R., Forny-Germano, L., Batista, A.F., Sathler, L.B., Brito-Moreira, J., Amaral, O.B., Silva, C.A., Freitas-Correa, L., Espirito-Santo, S., Campello-Costa, P., Houzel, J.C., Klein, W.L., Holscher, C., Carvalheira, J.B., Silva, A.M., Velloso, L.A., Munoz, D.P., Ferreira, S.T., De Felice, F.G., TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's beta-amyloid oligomers in mice and monkeys. Cell Metab. 18 (2013), 831–843.
79. Lu, Y., Christian, K., Lu, B., BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?. Neurobiol. Learn. Mem. 89 (2008), 312–323.
80. Maly, D.J., Papa, F.R., Druggable sensors of the unfolded protein response. Nat. Chem. Biol. 10 (2014), 892–901.
81. Martin, I., Dawson, V.L., Dawson, T.M., Recent advances in the genetics of Parkinson's disease. Annu. Rev. Genom. Hum. Genet. 12 (2011), 301–325.
82. Martinez, G., Vidal, R.L., Mardones, P., Serrano, F.G., Ardiles, A.O., Wirth, C., Valdes, P., Thielen, P., Schneider, B.L., Kerr, B., Valdes, J.L., Palacios, A.G., Inestrosa, N.C., Glimcher, L.H., Hetz, C., Regulation of memory formation by the transcription factor XBP1. Cell Rep. 14 (2016), 1382–1394.
83. Martinon, F., Chen, X., Lee, A.H., Glimcher, L.H., TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat. Immunol. 11 (2010), 411–418.
84. Matus, S., Castillo, K., Hetz, C., Hormesis: protecting neurons against cellular stress in Parkinson disease. Autophagy 8 (2012), 997–1001.
85. Matus, S., Lopez, E., Valenzuela, V., Nassif, M., Hetz, C., Functional contribution of the transcription factor ATF4 to the pathogenesis of amyotrophic lateral sclerosis. PLoS One, 8, 2013, e66672.
86. Matus, S., Valenzuela, V., Medinas, D.B., Hetz, C., ER dysfunction and protein folding stress in ALS. Int. J. Cell Biol., 2013, 2013, 674751.
87. Matus, S., Medinas, D.B., Hetz, C., Common ground: stem cell approaches find shared pathways underlying ALS. Cell Stem Cell 14 (2014), 697–699.
88. Maurel, M., Chevet, E., Tavernier, J., Gerlo, S., Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem. Sci. 39 (2014), 245–254.
89. McGeer, P.L., McGeer, E.G., NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol. Aging 28 (2007), 639–647.
90. Mercado, G., Valdes, P., Hetz, C., An ERcentric view of Parkinson's disease. Trends Mol. Med. 19 (2013), 165–175.
91. Mercado, G., Castillo, V., Vidal, R., Hetz, C., ER proteostasis disturbances in Parkinson's disease: novel insights. Front. Aging Neurosci., 7, 2015, 39.
92. Mollereau, B., Rzechorzek, N.M., Roussel, B.D., Sedru, M., VandenBrink, D.M., Bailly-Maitre, B., Palladino, F., Medinas, D.B., Domingos, P.M., Hunot, S., Chandran, S., Birman, S., Baron, T., Vivien, D., Duarte, C.B., Ryoo, H.D., Steller, H., Urano, F., Chevet, E., Kroemer, G., Ciechanover, A., Calabrese, E.J., Kaufman, R.J., Hetz, C., Adaptive preconditioning in neurological diseases - therapeutic insights from proteostatic perturbations. Brain Res, 2016, 10.1016/j.brainres.2016.02.033 (Epub ahead of print).
93. Moreno, J.A., Radford, H., Peretti, D., Steinert, J.R., Verity, N., Martin, M.G., Halliday, M., Morgan, J., Dinsdale, D., Ortori, C.A., Barrett, D.A., Tsaytler, P., Bertolotti, A., Willis, A.E., Bushell, M., Mallucci, G.R., Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration. Nature 485 (2012), 507–511.
94. Mucke, L., Selkoe, D.J., Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med., 2, 2012, a006338.
95. Nair, V.P., Anang, S., Subramani, C., Madhvi, A., Bakshi, K., Srivastava, A., Shalimar, Nayak, B., Ct, R.K., Surjit, M., Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus. Plos. Pathog., 12, 2016, e1005521.
96. Naujock, M., Stanslowsky, N., Bufler, S., Naumann, M., Reinhardt, P., Sterneckert, J., Kefalakes, E., Kassebaum, C., Bursch, F., Lojewski, X., Storch, A., Frickenhaus, M., Boeckers, T.M., Putz, S., Demstre, M., Liebau, S., Klingenstein, M., Ludolph, A.C., Dengler, R., Kim, K.S., Hermann, A., Wegner, F., Petri, S., 4-Aminopyridine induced activity rescues hypoexcitable motor neurons from als patient-derived induced pluripotent stem cells. Stem Cells, 2016.
97. Nishitoh, H., Kadowaki, H., Nagai, A., Maruyama, T., Yokota, T., Fukutomi, H., Noguchi, T., Matsuzawa, A., Takeda, K., Ichijo, H., ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 22 (2008), 1451–1464.
98. Oakes, S.A., Papa, F.R., The role of endoplasmic reticulum stress in human pathology. Annu. Rev. Pathol. 10 (2015), 173–194.
99. Onate, M., Catenaccio, A., Martinez, G., Armentano, D., Parsons, G., Kerr, B., Hetz, C., Court, F.A., Activation of the unfolded protein response promotes axonal regeneration after peripheral nerve injury. Sci. Rep., 6, 2016, 21709.
100. Osorio, F., Tavernier, S.J., Hoffmann, E., Saeys, Y., Martens, L., Vetters, J., Delrue, I., De Rycke, R., Parthoens, E., Pouliot, P., Iwawaki, T., Janssens, S., Lambrecht, B.N., The unfolded-protein-response sensor IRE-1alpha regulates the function of CD8alpha+ dendritic cells. Nat. Immunol. 15 (2014), 248–257.
101. Peters, O.M., Ghasemi, M., Brown, R.H. Jr., Emerging mechanisms of molecular pathology in ALS. J. Clin. Investig., 125, 2015, 2548.
102. Powell, S.K., Rivera-Soto, R., Gray, S.J., Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy. Discov. Med. 19 (2015), 49–57.
103. Rozas, P., Bargsted, L., Martinez, F., Hetz, C., Medinas, D., The ER proteostasis network in ALS: explaining the differential motoneuron vulnerability. Neurosci. Lett., 2016, 10.1016/j.neulet.2016.04.066.
104. Sado, M., Yamasaki, Y., Iwanaga, T., Onaka, Y., Ibuki, T., Nishihara, S., Mizuguchi, H., Momota, H., Kishibuchi, R., Hashimoto, T., Wada, D., Kitagawa, H., Watanabe, T.K., Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Res. 1257 (2009), 16–24.
105. Saxena, S., Cabuy, E., Caroni, P., A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 12 (2009), 627–636.
106. Saxena, S., Caroni, P., Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71 (2011), 35–48.
107. Scheper, W., Hoozemans, J.J., The unfolded protein response in neurodegenerative diseases: a neuropathological perspective. Acta Neuropathol. 130:3 (2015), 315–331, 10.1007/s00401-015-1462-8.
108. Schimmer, J., Breazzano, S., Investor outlook: significance of the positive LCA2 gene therapy Phase III results. Hum. Gene Ther. Clin. Dev. 26 (2015), 208–210.
109. Schimmer, J., Breazzano, S., Yang, J., 2016. Gene Therapy 2016 Update and Outlook; Tracking the Progress. In: Industry Note, vol. 1, ed. PiperJaffray.
110. Selvaraj, S., Sun, Y., Watt, J.A., Wang, S., Lei, S., Birnbaumer, L., Singh, B.B., Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling. J. Clin. Investig. 122 (2012), 1354–1367.
111. Shankar, G.M., Li, S., Mehta, T.H., Garcia-Munoz, A., Shepardson, N.E., Smith, I., Brett, F.M., Farrell, M.A., Rowan, M.J., Lemere, C.A., Regan, C.M., Walsh, D.M., Sabatini, B.L., Selkoe, D.J., Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14 (2008), 837–842.
112. Shimazawa, M., Tanaka, H., Ito, Y., Morimoto, N., Tsuruma, K., Kadokura, M., Tamura, S., Inoue, T., Yamada, M., Takahashi, H., Warita, H., Aoki, M., Hara, H., An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS. PLoS One, 5, 2010, e15307.
113. Silva, R.M., Ries, V., Oo, T.F., Yarygina, O., Jackson-Lewis, V., Ryu, E.J., Lu, P.D., Marciniak, S.J., Ron, D., Przedborski, S., Kholodilov, N., Greene, L.A., Burke, R.E., CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism. J. Neurochem. 95 (2005), 974–986.
114. Slodzinski, H., Moran, L.B., Michael, G.J., Wang, B., Novoselov, S., Cheetham, M.E., Pearce, R.K., Graeber, M.B., Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies. Clin. Neuropathol. 28 (2009), 333–343.
115. Soto, C., Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4 (2003), 49–60.
116. Sun, S., Sun, Y., Ling, S.C., Ferraiuolo, L., McAlonis-Downes, M., Zou, Y., Drenner, K., Wang, Y., Ditsworth, D., Tokunaga, S., Kopelevich, A., Kaspar, B.K., Lagier-Tourenne, C., Cleveland, D.W., Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc. Natl. Acad. Sci. USA 112 (2015), E6993–E7002.
117. Tabas, I., Ron, D., Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13 (2011), 184–190.
118. Tanguy, Y., Biferi, M.G., Besse, A., Astord, S., Cohen-Tannoudji, M., Marais, T., Barkats, M., Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice. Front. Mol. Neurosci., 8, 2015, 36.
119. Torres, M., Medinas, D.B., Matamala, J.M., Woehlbier, U., Cornejo, V.H., Solda, T., Andreu, C., Rozas, P., Matus, S., Munoz, N., Vergara, C., Cartier, L., Soto, C., Molinari, M., Hetz, C., The protein-disulfide isomerase ERp57 regulates the steady-state levels of the prion protein. J. Biol. Chem. 290 (2015), 23631–23645.
120. Towne, C., Schneider, B.L., Kieran, D., Redmond, D.E. Jr., Aebischer, P., Efficient transduction of non-human primate motor neurons after intramuscular delivery of recombinant AAV serotype 6. Gene Ther. 17 (2010), 141–146.
121. Tsaytler, P., Bertolotti, A., Exploiting the selectivity of protein phosphatase 1 for pharmacological intervention. FEBS J. 280 (2013), 766–770.
122. Turner, M.R., Hardiman, O., Benatar, M., Brooks, B.R., Chio, A., de Carvalho, M., Ince, P.G., Lin, C., Miller, R.G., Mitsumoto, H., Nicholson, G., Ravits, J., Shaw, P.J., Swash, M., Talbot, K., Traynor, B.J., Van den Berg, L.H., Veldink, J.H., Vucic, S., Kiernan, M.C., Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 12 (2013), 310–322.
123. Urra, H., Dufey, E., Lisbona, F., Rojas-Rivera, D., Hetz, C., When ER stress reaches a dead end. Biochim. Biophys. Acta 1833 (2013), 3507–3517.
124. Valdes, P., Mercado, G., Vidal, R.L., Molina, C., Parsons, G., Court, F.A., Martinez, A., Galleguillos, D., Armentano, D., Schneider, B.L., Hetz, C., Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1. Proc. Natl. Acad. Sci. USA 111 (2014), 6804–6809.
125. Valenzuela, V., Collyer, E., Armentano, D., Parsons, G.B., Court, F.A., Hetz, C., Activation of the unfolded protein response enhances motor recovery after spinal cord injury. Cell Death Dis., 3, 2012, e272.
126. Vidal, R.L., Figueroa, A., Court, F.A., Thielen, P., Molina, C., Wirth, C., Caballero, B., Kiffin, R., Segura-Aguilar, J., Cuervo, A.M., Glimcher, L.H., Hetz, C., Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy. Hum. Mol. Genet. 21 (2012), 2245–2262.
127. Vidal, R.L., Matus, S., Bargsted, L., Hetz, C., Targeting autophagy in neurodegenerative diseases. Trends Pharmacol. Sci. 35 (2014), 583–591.
128. Vieira, F.G., Ping, Q., Moreno, A.J., Kidd, J.D., Thompson, K., Jiang, B., Lincecum, J.M., Wang, M.Z., De Zutter, G.S., Tassinari, V.R., Levine, B., Hatzipetros, T., Gill, A., Perrin, S., Guanabenz treatment accelerates disease in a mutant SOD1 mouse model of ALS. PLoS One, 10, 2015, e0135570.
129. Walter, P., Ron, D., The unfolded protein response: from stress pathway to homeostatic regulation. Science 334 (2011), 1081–1086.
130. Wang, D., Gao, G., State-of-the-art human gene therapy: Part II. Gene therapy strategies and clinical applications. Discov. Med. 18 (2014), 151–161.
131. Wang, D., Gao, G., State-of-the-art human gene therapy: Part I. Gene delivery technologies. Discov. Med. 18 (2014), 67–77.
132. Wang, I.F., Guo, B.S., Liu, Y.C., Wu, C.C., Yang, C.H., Tsai, K.J., Shen, C.K., Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. USA 109 (2012), 15024–15029.
133. Wang, L., Popko, B., Roos, R.P., The unfolded protein response in familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 20 (2011), 1008–1015.
134. Wang, L., Popko, B., Tixier, E., Roos, R.P., Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis. Neurobiol. Dis. 71 (2014), 317–324.
135. Weinberg, M.S., Samulski, R.J., McCown, T.J., Adeno-associated virus (AAV) gene therapy for neurological disease. Neuropharmacology 69 (2013), 82–88.
136. Weismann, C.M., Ferreira, J., Keeler, A.M., Su, Q., Qui, L., Shaffer, S.A., Xu, Z., Gao, G., Sena-Esteves, M., Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan. Hum. Mol. Genet. 24 (2015), 4353–4364.
137. Woehlbier, U., Colombo, A., Saaranen, M.J., Perez, V., Ojeda, J., Bustos, F.J., Andreu, C.I., Torres, M., Valenzuela, V., Medinas, D.B., Rozas, P., Vidal, R.L., Lopez-Gonzalez, R., Salameh, J., Fernandez-Collemann, S., Munoz, N., Matus, S., Armisen, R., Sagredo, A., Palma, K., Irrazabal, T., Almeida, S., Gonzalez-Perez, P., Campero, M., Gao, F.B., Henny, P., van Zundert, B., Ruddock, L.W., Concha, M.L., Henriquez, J.P., Brown, R.H., Hetz, C., ALS-linked protein disulfide isomerase variants cause motor dysfunction. EMBO J., 2016.
138. Yamamoto, K., Sato, T., Matsui, T., Sato, M., Okada, T., Yoshida, H., Harada, A., Mori, K., Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1. Dev. Cell 13 (2007), 365–376.
139. Yoon, S.O., Park, D.J., Ryu, J.C., Ozer, H.G., Tep, C., Shin, Y.J., Lim, T.H., Pastorino, L., Kunwar, A.J., Walton, J.C., Nagahara, A.H., Lu, K.P., Nelson, R.J., Tuszynski, M.H., Huang, K., JNK3 perpetuates metabolic stress induced by abeta peptides. Neuron 75 (2012), 824–837.
140. Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., Mori, K., XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107 (2001), 881–891.
141. Yu, C.Y., Hsu, Y.W., Liao, C.L., Lin, Y.L., Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J. Virol. 80 (2006), 11868–11880.
142. Zhang, H., Yang, B., Mu, X., Ahmed, S.S., Su, Q., He, R., Wang, H., Mueller, C., Sena-Esteves, M., Brown, R., Xu, Z., Gao, G., Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol. Ther.: J. Am. Soc. Gene Ther. 19 (2011), 1440–1448.
143. Zhu, P.J., Huang, W., Kalikulov, D., Yoo, J.W., Placzek, A.N., Stoica, L., Zhou, H., Bell, J.C., Friedlander, M.J., Krnjevic, K., Noebels, J.L., Costa-Mattioli, M., Suppression of PKR promotes network excitability and enhanced cognition by interferon-gamma-mediated disinhibition. Cell 147 (2011), 1384–1396.
144. Zuleta, A., Vidal, R.L., Armentano, D., Parsons, G., Hetz, C., AAV-mediated delivery of the transcription factor XBP1s into the striatum reduces mutant Huntingtin aggregation in a mouse model of Huntington's disease. Biochem. Biophys. Res. Commun. 420 (2012), 558–563.